Therapeutic Asset Ratings
13,155 results matching 1 filter
91,564 assets · 7,904 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Midazolam
Bipolar I Disorder
Joshua Rosenblat
P2
B
(61)
Midazolam
Bipolar II Disorder
Joshua Rosenblat
P2
B
(61)
Nilotinib
Refractory Malignant Neoplasm
National Cancer Institute (NCI)
P2
B
(61)
Niraparib
Pancreatic Adenocarcinoma
Abramson Cancer Center at Penn Medicine
P2
B
(61)
Nivestim
Cancer
Roswell Park Cancer Institute
P2
B
(61)
Nivolumab
Cholangiocarcinoma
Instituto do Cancer do Estado de São Paulo
P2
B
(61)
Nivolumab
Gastroesophageal Junction Adenocarcinoma
I-Mab Biopharma US Limited
P2
B
(61)
Nivolumab
Relapsed/Refractory Diffuse Large B-Cell Lymphoma
National Cancer Institute (NCI)
P2
B
(61)
NORVIR
Metastatic Prostate Carcinoma
University of Chicago
P2
B
(61)
Olaparib
Malignant Glioma
Fundación de investigación HM
P2
B
(61)
Osimertinib
Lung Neoplasm
Jin Ying
P2
B
(61)
Pembrolizumab
Metastatic Malignant Neoplasm In The Brain
City of Hope Medical Center
P2
B
(61)
Pembrolizumab
Castration-Resistant Prostate Carcinoma
Cellbion Co., Ltd.
P2
B
(61)
Pembrolizumab
Estrogen-Receptor Positive Breast Cancer
UNC Lineberger Comprehensive Cancer Center
P2
B
(61)
Pembrolizumab
Gastroesophageal Cancer
Diwakar Davar
P2
B
(61)
Pembrolizumab
Prostate Adenocarcinoma
OHSU Knight Cancer Institute
P2
B
(61)
Pentanoic Acid, 2-Amino-5,5-Difluoro-4,4-Dimethyl-, (2S)-
Major Depressive Disorder
Navitor Pharmaceuticals, Inc.
P2
B
(61)
Pirtobrutinib
Diffuse Large B-Cell Lymphoma
The First Affiliated Hospital of Soochow University
P2
B
(61)
Plinabulin
Small Cell Lung Carcinoma
Xiaorong Dong
P2
B
(61)
Polatuzumab Vedotin
Follicular Lymphoma
City of Hope Medical Center
P2
B
(61)
Pralatrexate
Anaplastic Large Cell Lymphoma
City of Hope Medical Center
P2
B
(61)
Prednisone
Chronic Myeloid Leukemia
M.D. Anderson Cancer Center
P2
B
(61)
Prednisone
Melanoma
National Cancer Institute (NCI)
P2
B
(61)
Resiquimod
Neoplasm
Eikon Therapeutics
P2
B
(61)
Resminostat
Primary Cutaneous T-Cell Non-Hodgkin Lymphoma
4SC AG
P2
B
(61)
Showing 1451 to 1475 of 13,155 assets
Previous
Page 59 of 527
Next